All In MedTech

Device Trial Radar · NCT04841304

Cardiac Arrhythmia in Patients With End-Stage Renal Disease

Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

70

Actual

Start

Jun 1, 2021

Primary completion

Apr 1, 2024

Study completion Mar 1, 2026

Sponsor

Lead sponsor
Copenhagen University Hospital, RigshospitaletAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Herlev Hospital; Steno Diabetes Center Copenhagen; University of Copenhagen; Hillerod Hospital, Denmark; Holbaek Sygehus
First posted
Apr 12, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will examine the presence of cardiac arrhythmias in patients receiving hemodialysis and the role of diabetes, hypoglycemia and parameters related to uremia and the dialysis procedure. The study is designed as a prospective cohort study with 18 months follow-up. 70 patients receiving chronic hemodialysis will be recruited and equipped with implantable loop recorders (ILR): 35 patients with diabetes and 35 patients without diabetes. Data collection during the follow-up includes continuous monitoring of the heart rhythm by the ILR for the entire follow-up period, continuous glucose monitoring for 10 days every second month, and monthly collection of blood samples and dialytic parameters. After the initial 18-month follow-up, heart rhythm monitoring will continue until the ILR battery runs out for those participants who wish to continue.

Conditions

  • End Stage Renal Disease on Dialysis
  • Cardiac Arrhythmia
  • Diabetes Mellitus
  • Hypoglycemia

Interventions

  • Loop recorder (Reveal LINQ, Medtronic)Device

    Implantation of a loop-recorder

  • Continuous Glucose Measurement (G6, Dexcom)Device

    Monitoring with a continuous glucose monitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinically significant arrhythmiasTime frame: 18 months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Department of Nephrology, Rigshospitalet

    Copenhagen, Denmark

  • Department of Nephrology, Herlev Hospital

    Herlev, Denmark

  • Department of Nephrology, North Zealand Hospital

    Hillerød, Denmark

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.